TESULOID Drug Patent Profile
Which patents cover Tesuloid, and when can generic versions of Tesuloid launch?
Tesuloid is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in TESULOID is technetium tc-99m sulfur colloid kit. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m sulfur colloid kit profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tesuloid
A generic version of TESULOID was approved as technetium tc-99m sulfur colloid kit by JUBILANT on November 9th, 2023.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TESULOID?
- What are the global sales for TESULOID?
- What is Average Wholesale Price for TESULOID?
Summary for TESULOID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 33 |
| DailyMed Link: | TESULOID at DailyMed |
US Patents and Regulatory Information for TESULOID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | TESULOID | technetium tc-99m sulfur colloid kit | SOLUTION;INJECTION, ORAL | 016923-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
